Background and Purpose-Previous estimates of the prevalence of silent cerebral infarction (SCI) on MRI in community-based samples have varied between 5.8% and 17.7% depending on age, ethnicity, presence of comorbidities, and imaging techniques. We document the prevalence and risk factors associated with SCI at midlife in the community-based Framingham sample. Methods-Our study sample comprised 2040 Framingham Offspring (53% female; mean age, 62Ϯ9 years) who attended the sixth examination (1996 ( -1998 ( ), underwent volumetric brain MRI (1999 and were free of clinical stroke at MRI. We examined the age-and sex-specific prevalences and the clinical correlates of SCI using multivariable logistic regression models. Results-At least 1 SCI was present in 10.7% of participants; 84% had a single lesion. SCI was largely located in the basal ganglia (52%), other subcortical (35%) areas, and cortical areas (11% 
S ilent cerebral infarctions (SCIs), also termed covert infarcts or simply MRI infarcts, are parenchymal lesions that have the MRI characteristics of previous infarcts but have not been associated in that individual with clinical signs or symptoms corresponding to a stroke. 1 They were first described by Fisher 2 in a cohort of 114 subjects who came to autopsy; 88 brains had at least 1 lacune in the absence of clinical deficits or a stroke history. In recent studies, the prevalence of SCI on MRI scans has ranged from 5.84% to 28%. 3, 4 Reasons for this variation in prevalence may include differences in the definition of SCI, in MRI techniques, age, sex, and risk factor profile of the population being studied. [3] [4] [5] [6] Risk factors associated with clinical stroke such as age, sex, diabetes mellitus, atrial fibrillation (AF), systolic blood pressure (SBP), and cigarette smoking have also been associated with SCIs. 1,4 -8 However there is a paucity of information on the association between SCI and other circulating biomarkers (such as plasma homocysteine [tHcy] and cholesterol concentrations) or intermediate phenotypes (such as carotid artery intimal medial thickness and left ventricular mass). 9 -12 Hence, we determined the prevalence of SCI in the Framingham Offspring Study sample and related risk factors comprising the Framingham Stroke Risk Profile (FSRP), as well other important cerebrovascular risk factors to prevalent SCI.
Participants and Methods

Study Sample
The Framingham Study is a longitudinal community-based study that began in 1948 with the recruitment of the original cohort. 13 Their offspring and offspring spouses were recruited in 1971 to form the Offspring cohort. 14 These Offspring have undergone serial clinical examinations every 4 to 8 years and are currently undergoing an eighth examination. At examination, 7 (1998 -2001) participants were invited to undergo brain MRI. Participants with claustrophobia, metal in the eyes or other body parts, valvular prosthesis, vascular clips, cardiac pacemakers, cochlear implants, or other implanted device sensitive to strong magnetic fields were excluded. Because some participants had brain MRI before their seventh baseline examination, we chose the sixth examination as the baseline for this study. Of 3532 participants who attended the sixth examination, 2100 underwent brain MRI. Participants with prevalent stroke or dementia or other neurological conditions that might confound the diagnosis of SCI on MRI were excluded. The remaining 2040 participants were evaluated for these analyses. This study was approved by the Institutional Review Board at Boston Medical Center, and all participants gave informed consent.
MRI Techniques
MRI techniques used in this study have been detailed elsewhere. 15 Briefly, participants were evaluated with a 1-tesla Siemens Magnetom. T2-weighted double spin-echo coronal-weighted sequences were acquired in 4-mm contiguous slices from nasion to occiput with a repetition time of 2420 ms, echo time of 20/90 ms, echo train length of 8 ms, field of view of 22 cm, and an acquisition matrix of 182ϫ256 interpolated to 256ϫ256 with 1 excitation. All images were transferred to the centralized reading center at the University of California-Davis Medical Center and analyses were performed on QUANTA 6.2, a custom-designed image analysis package operating on a Sun Microsystems Ultra 5 workstation. The presence of MRI infarction was determined from the size, location, and imaging characteristics of the lesion. The image analysis system allowed for superimposition of the subtraction image (PD-T2), the proton density image, and the T2-weighted image at 3ϫ magnification to assist in interpretation of lesion characteristics. Signal void, best seen on the T2-weighted image, was interpreted to indicate a vessel. Only lesions larger than 3 mm were considered infarcts. Lesions were also required to have cerebrospinal fluid density on subtraction images and to be distinctly separate from the circle of Willis vessels for suspected basal ganglia infarcts. Investigators blinded to subject demographic and stroke risk factor data processed and analyzed these scans. Scans were evaluated by 3 different raters. Kappa values for agreement ranged between 0.73 and 0.90. 15 
Definition of MRI Infarct as SCI: Exclusion of Clinical Stroke
MRI infarcts in persons without a clinical stroke documented by the Framingham Stroke surveillance team were considered SCI. Details regarding stroke surveillance and ascertainment have been detailed in previous publications. 16 Information regarding stroke symptoms was elicited using a structured questionnaire administered by a physician at each examination cycle. If participants reported a history suggestive of stroke or TIA or demonstrated neurological abnormalities, then they were evaluated further by a study neurologist. Additional surveillance was performed through annual telephone health updates and by the daily monitoring of admissions at the only acute care hospital in Framingham, Mass. All participants admitted to the hospital were evaluated by a study neurologist if cerebrovascular disease was suspected. Finally, participants underwent neurology assessment if they, their family, primary care physicians, or personnel in an ancillary study referred them for possible stroke. The final determination regarding the presence and absence of stroke, type, and location was made at a stroke review by at least 2 neurologists with access to all Framingham and outside records, including brain imaging. SCI can also be defined as MRI infarcts in subjects known not to have experienced either a clinical stroke or TIA before MRI, because some persons with clinical TIA have MRI lesions seen acutely on diffusion-weighted MRI. 17 We chose not to use this definition because the determination of whether a TIA occurred, although based on the same review process used for clinical stroke, is, based on history alone, more subjective than stroke ascertainment. Finally, SCI can be defined after exclusion of lesions that correspond anatomically to documented past clinical events: either completed stroke or TIA. This last definition would permit inclusion of SCI in persons who have multiple MRI infarcts but fewer clinical events. We did not use this method, choosing instead to maintain blinded reading of MRI scans without reference to clinical data.
Independent Variables
We evaluated components of the FSRP, other vascular risk factors, and intermediate phenotypes. The FSRP is a validated instrument that estimates the 10-year probability of incident stroke. The component factors of the FSRP are age, SBP, antihypertensive therapy, diabetes mellitus, cigarette smoking, cardiovascular disease, AF, and left ventricular hypertrophy on electrocardiographic criteria. 18, 19 SBP was recorded as the average of 2 physician-generated measurements. Participants were dichotomized according to baseline use of antihypertensive drugs and current smoking or nonsmoking status. Diabetes mellitus was defined as random blood glucose Ն200 mg/dL (11 mmol/dL), a previous diagnosis of diabetes or use of a hypoglycemic medication or insulin; previous cardiovascular disease included coronary artery disease, congestive heart failure, and peripheral vascular disease. AF and left ventricular hypertrophy data were obtained from a standard 12-lead ECG completed at or before the baseline examination. 20 All participants underwent transthoracic B-mode echocardiogram. Left ventricular internal dimensions, posterior ventricular wall thickness, and interventricular septum thickness were measured at enddiastole; these measurement were used to generate left ventricular mass using formulae described elsewhere. 21 Left ventricular mass was indexed to subject height.
Carotid imaging was conducted using Toshiba Medical Systems 7.5-Mhz transducer for the common carotid artery. A 5.0-MHz transducer was used for the carotid bulb and internal carotid artery. All measurements were performed by one trained sonographer blinded to clinical data. Two images each at the distal common carotid artery, the carotid bulb, and the proximal 2 cm of the internal carotid artery were obtained. Carotid artery stenosis was defined as Ͻ49% when velocities were Ͻ150 cms/sec and Ն50% if the velocity was Ն150 cm/sec. Measures of carotid intima media thickness (IMT) were generated at each of the 3 sites imaged. The maximal IMT at each site was defined as the mean of maximal IMT measurements of the near and far wall; common carotid artery IMT (CCA IMT) was therefore the mean of the IMTs for the left and right common carotid arteries. 22 Total, low-density lipoprotein, and high-density lipoprotein were obtained after a 12-hour fast using the Lipid Research Clinics method. Cholesterol levels were measured using Abel Kendall method, 23 whereas tHcy levels were measured by high-performance liquid chromatography with fluorometric technique. 24 
Statistical Analysis
Our primary outcome variable was prevalent SCI on MRI scans obtained at the seventh biennial examination. Logistic regression adjusted for age and sex was used to relate the variables that comprise the FSRP, tHcy levels, left ventricular mass, and carotid IMT to the risk of prevalent silent infarcts. Variables with skewed distributions were log-transformed. In addition, for those variables, we compared the top quartile to the lower 3 quartiles. For continuous risk factors, results are presented as the effect of an increase of 1 standard deviation. We investigated potential effect modification by sex and age using models with interaction terms. All analyses were performed with PC-SAS software 9.1 (SAS Institute Inc).
Using statistical methods described elsewhere, 25 we calculated population-attributable risks for prevalent SCIs. The populationattributable risk is the proportion of disease in the population attributable to the risk factor studied.
Results
Demographic and risk factor prevalence data for the study sample and the subgroup of persons with SCI are shown in Table 1 . SCI was present in 10.7% of 2040 Offspring studied. Participants with SCI were slightly older (mean age, 61 years vs 58 years for the entire sample) and had a higher SBP. Age-specific and sex-specific data on SCI prevalence are shown in Figure 1 . The prevalence of SCI varied with age, increasing from Ͻ8% in the group aged 30 to 49 years to Ͼ15% at age 70 to 89 years. Single SCI occurred in 185 participants (84.1%) and were most commonly located in the basal ganglia (51.9%). SCI were subcortical in 34.8%, whereas 11% of lesions were cortical. Location data for prevalent SCI are presented in Figure 2 .
The results of logistic regression analyses are provided in Table 2 . Neither age nor gender significantly modified the effect of any of the risk factors on prevalence of SCI. Additionally, we did not observe any significant age-sex interaction. The aggregate FSRP score was significantly related to prevalent SCI. Of the variables comprising the FSRP, AF, hypertension, and SBP were each associated with an increased risk of SCI. Among variables that were not components of the FSRP, plasma tHcy and carotid artery stenosis Ն25% were associated with a higher risk of prevalent SCI. Plasma tHcy as a continuous variable, as well as a value in the highest quartile (compared with the lower 3 quartiles), was related to prevalent SCI. Carotid artery stenosis Ն25%, higher CCA IMT, higher internal carotid artery (ICA) IMT, and the highest quartile of ICA IMT as compared to the lower 3 quartiles were also significantly associated with prevalent SCI. The portion of disease in the population attributable to individual risk factors, the populationattributable risks, was 16.6% for hypertension, whereas it was 8.2% for carotid artery disease and elevated serum homocysteine, and it was 3.1% for atrial fibrillation.
Discussion
Among clinically stroke-free participants in this mid-life, community-dwelling cohort, 10.7% had SCI on routine brain MRI. Although previous studies have also reported a significant association of hypertension and tHcy with prevalent SCI, ours is the first study to our knowledge to demonstrate a significant relationship between AF and SCI. Ours is also the first study to our knowledge to evaluate the effect of left ventricular mass on SCI prevalence. The association of these risk factors for clinical stroke with subclinical SCI is not surprising but reinforces the importance of early detection and treatment of cardiovascular risk factors in mid-life. This is especially true because SCI has been associated with an increased risk of incident stroke and cognitive impairment. 26 Previous cohort studies have reported a prevalence of SCI on MRI 4 -6,27 varying from 11% in the younger participants (mean age, 63 years; range, 55-70 years) within the Atherosclerosis Risk in Communities study to 20% in the older participants of the Rotterdam Scan Study and 28% in the Cardiovascular Health Study (CHS) sample; mean age was 76 years in both the CHS and Rotterdam Scan Study. 4, 6 However, autopsy data from 966 brains in the Hisayama Study evaluating asymptomatic community-dwelling adults (mean age, 74 years) disclosed a lower 12.9% prevalence of SCI, perhaps related to failure to count some SCI at autopsy, or related to ethnic differences. 27 MRI is reliably sensitive in identifying autopsy-confirmed cerebral infarcts. 28, 29 In our sample, the prevalence of SCI increases with advancing age in both men and women, which is consistent with previous studies. 4, 5, 27 Vermeer et al 5 reported a 30% higher overall prevalence of SCI in women compared to men in all age groups. However, we did not find a significant sex difference in the prevalence of SCI, and neither did the Atherosclerosis Risk in Communities and CHS studies. 4 Studies have also differed on imaging criteria and technology. MRI scanners used in population studies have varied between field strengths of 1.0 to 1.5 tesla, slice thicknesses of 5 to 8 mm, and an interslice gap of 0% to 20% percent. 4, 5, 9 Previous studies share with our study well-defined MRI criteria for infarcts. However, our study was the only one to require a distinct separation between basal ganglial SCI and circle of Willis vessels, perhaps thereby improving diagnostic specificity. CHS additionally reported the prevalence of lesions Ͻ3 mm and designated these as small infarct-like lesions; these lesions had a prevalence of 7.8% and were associated with memory loss. 4 We did not assess SCI Ͻ3 mm. We observed that more than four-fifths of our participants with SCI had a single lesion. In the Hisayama study, 12 70% of participants with SCI had Յ2 infarcts, whereas Kwon et al 27 found that 70% had a single lesion. Lee et al 3 described single lesion SCIs in 72%.
We observed a similar distribution of SCI to that noted in previous studies; more than half were in the basal ganglia, one-third were subcortical, and one-tenth were cortical. In CHS, 72% were subcortical, and in the Rotterdam Scan Study 80% were basal ganglia lesions. 4, 5 Lee et al 3 noted that 38% were in the basal ganglia, one-quarter were periventricular, 12% were thalamic, and 9% were pontine. It has been speculated that SCIs are silent (or rather produce subtle neurological damage) because they occur in clinically ineloquent areas of the brain 3 ; the predominance of lesions in the basal ganglia and their being found subcortically rather than cortically appear to support this hypothesis.
The FSRP has been previously associated with incident clinical stroke, total brain volume, and prevalent white matter hyperintensity volume. 20, 30 We have shown that the FSRP score was also associated with an increased risk of prevalent SCI. Additionally, the individual components of the FSRP were evaluated for their impact on SCI prevalence but, with the exception of SBP, hypertension, and AF, there were no other significant relationships. However, all the components of the FSRP were positively associated with an increased prevalence of SCI, although the relationships failed to reach statistical significance for some components. Whereas previ- ous studies have related the individual components of the FSRP to prevalent SCI, this is the first study to our knowledge to relate the aggregate score to prevalence of silent strokes. Hypertension has consistently been implicated as a risk factor for SCI. 1 Vermeer 5 demonstrated Ͼ2-fold increase in SCI in the Rotterdam Scan Study. However, Lee et al 3 showed Ͼ3-fold increase in SCI prevalence in those with hypertension. At autopsy, Shinkawa et al 27 found that SCI and non-SCI brains differed significantly with regard to diastolic blood pressure measurements. In our study we demonstrated that hypertension and elevated SBP are important risk factors for SCI.
In our data, AF increased the risk of prevalent SCI Ͼ2-fold. AF is known to be an important risk factor for clinical stroke, associated with a 5-fold increase in stroke incidence. 31 In previous studies of persons with AF and no known clinical stroke, the prevalence of SCI on CT scans, in studies that have varied in sample size, has ranged from 13% to 48%. 7, 8, [32] [33] [34] In the Hisayama autopsy study, 27 persons with SCI at autopsy had a significantly higher frequency of AF before death than persons without SCI (10.7% vs 3.9%). In a study of 994 healthy middle-aged adults undergoing a screening medical examination with brain MRI, Lee et al 3 did not observe an association between prevalent SCI and AF; this may be explained by the lower mean age (49 years) of their sample, more than a decade younger than the Framingham Offspring at the time of MRI. The other large communitybased cohorts did not evaluate AF as an SCI risk factor, or found it nonsignificant. 4 -6,35 Risk factors for stroke generally and perhaps SCI in particular are also risk factors for AF. Thus, hypertension, previous cardiovascular disease and MI, and diabetes, which predispose to AF, also predispose to clinical stroke and, probably, to SCI. In this way, AF may be a concomitant outcome rather than the mechanism underlying the occurrence of SCI.
In this study, carotid artery stenosis Ն25% was associated with an increased prevalence of SCI. In the CHS study, participants with carotid stenosis Ն75% had nearly twice the likelihood of prevalent SCI on MRI. 36 Uehara et al 37 evaluated MRI in 219 stroke-free participants who had presented to the hospital with nonspecific neurological symptoms. Carotid artery stenosis Ͼ25% on MRA was associated with a 3-fold increased risk of basal ganglial SCIs on multivariate analysis. 37 It is known that carotid artery stenosis may serve as an embolic source for cerebrovascular lesions; Norris and Zhu 38 report a direct relationship between degree of stenosis and the frequency of both overt and silent stroke in a population that included participants with carotid distribution transient ischemic attacks. The pathogenetic mechanism, however, is unclear. In 108 participants, convergent color Doppler revealed greater turbulence in ICAs with stenosis Ͼ50% if the participants also had an SCI on brain MRI than in those without an SCI. 39 Uehara, 37 however, found that there was no statistically significant difference in the prevalence of SCIs in the territory served by the stenosed carotid as compared to that of the nonstenosed artery. This is similar to previous data from Framingham, 40 and to data from the Asymptomatic Carotid Atherosclerosis Study, suggesting that carotid artery disease may be a marker for atherosclerotic disease rather than the direct proximate cause of SCI. 41 In our study, CCA IMT was significantly associated with prevalence of SCI, as was ICA IMT. CCA IMT is known to predict clinical vascular outcomes, including stroke and MI. 42, 43 Previous studies have related CCA IMT and ICA IMT to clinical stroke. 44 A single Japanese study 11 observed an association between CCA IMT and prevalent MRI infarcts in 28 adults, but it was not clear whether the observed MRI infarcts were silent because no history regarding previous stroke had been obtained. In the CHS study, 36 prevalent SCI were associated with both CCA IMT and ICA IMT.
Two previous studies have evaluated the effect of elevated circulating tHcy concentrations on prevalent SCI. Matsui et al 9 examined 153 elderly community-dwelling participants with cranial MRI. Individuals in the highest and middle tertiles of plasma tHcy had Ͼ4-times and nearly 3-times the risk of SCI, respectively, compared to persons in the lowest tertile. 9 In the Rotterdam Scan Study, participants in the upper quintile had Ϸ2.5-times the risk of SCI compared to persons in the lowest quintile. 10 The results of our study are consistent with the literature. We demonstrate an increased prevalence of SCI in association with the plasma homocysteine level; elevated tHcy is known to be associated with an increased incidence of stroke and MI. 44 Pathogenetic hypotheses for SCI have included dysregulated cerebral blood flow from hypertension and vascular disease, large vessel atherothrombosis, as well as from cerebral emboli. 1, 45 Risk factors that proved significant for prevalent SCI remain those that fit the mechanisms of hypertension, atrial fibrillation, hyperhomocystinemia, and carotid artery disease.
The strengths of evaluating the prevalence and risk factors for SCI using data from the Framingham Offspring Study include the use of previously validated MRI imaging to assess the presence or absence of MRI infarcts and the wellvalidated ongoing surveillance for clinical stroke, which minimizes the probability of clinically symptomatic events being misclassified as SCI. In the past, studies have used differing methods to determine clinical history with regard to stroke symptomatology. Some 3, 6 have relied on subject selfreport, and others 5 have relied on both self-report and evaluation of participants' medical records. A few 4, 27 have used periodic visits and surveillance of hospital admission. In our study, surveillance techniques include systematic history taking for symptoms suggestive of stroke or TIA at each biennial health evaluation and active daily surveillance of admissions to the local hospital.
Participants in the Framingham Study are largely of European descent. This limits the generalizability of our findings to other ethnic groups. Ethnic differences have been described in other multi-ethnic cohorts such as the Northern Manhattan Study. 46 A second limitation of this study is the lack of incidence data, given that the participants underwent a single cranial MRI.
In conclusion, we document a 10.7% prevalence of SCI in a community-based sample. This is concerning because SCI has been related both to the risk of incident stroke and to cognitive impairment. 26 The significant relationship between
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hypertension, elevated plasma homocysteine, as well as carotid artery disease and prevalent SCI underscores the importance of current guidelines for the early diagnosis and prevention of hypertension and atherosclerosis and their risk factors. AF is also associated with SCI, although our observational data cannot show if screening for and appropriately treating AF would reduce the population burden of SCI.
Sources of Funding
This work was supported by the Framingham Heart Study's National Heart, Lung, and Blood Institute contract (N01-HC-25195), and by grants from the National Institute on Aging (R01 AG16495; AG08122) and the National Institute of Neurological Disorders and Stroke (R01 NS17950).
